Molecule Holdings Inc. Logo

Molecule Holdings Inc.

EVRRF

(0.0)
Stock Price

0,00 USD

-44.91% ROA

27.08% ROE

-0.23x PER

Market Cap.

244.455,00 USD

-103.62% DER

0% Yield

-161.57% NPM

Molecule Holdings Inc. Stock Analysis

Molecule Holdings Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Molecule Holdings Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Molecule Holdings Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Molecule Holdings Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Molecule Holdings Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Molecule Holdings Inc. Revenue
Year Revenue Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 367.437 100%
2022 1.444.410 74.56%
2023 2.165.396 33.3%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Molecule Holdings Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Molecule Holdings Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 1.069.122 100%
2020 1.822.793 41.35%
2021 2.426.183 24.87%
2022 2.588.121 6.26%
2023 2.044.208 -26.61%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Molecule Holdings Inc. EBITDA
Year EBITDA Growth
2015 -345.687
2016 -653.848 47.13%
2017 -415.941 -57.2%
2018 -222.471 -86.96%
2019 -813.421 72.65%
2020 -1.336.340 39.13%
2021 -2.576.142 48.13%
2022 -2.843.181 9.39%
2023 -816.864 -248.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Molecule Holdings Inc. Gross Profit
Year Gross Profit Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 -21.292 100%
2020 -35.981 40.82%
2021 -566.794 93.65%
2022 -817.260 30.65%
2023 624.984 230.76%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Molecule Holdings Inc. Net Profit
Year Net Profit Growth
2015 -3.402.263
2016 -823.141 -313.33%
2017 -8.307.323 90.09%
2018 -263.481 -3052.91%
2019 -830.256 68.27%
2020 -2.495.214 66.73%
2021 -3.411.896 26.87%
2022 -3.334.329 -2.33%
2023 -2.385.684 -39.76%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Molecule Holdings Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 -1
2016 0 0%
2017 -1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Molecule Holdings Inc. Free Cashflow
Year Free Cashflow Growth
2015 -636.566
2016 -718.956 11.46%
2017 -886.485 18.9%
2018 -211.363 -319.41%
2019 -1.884.180 88.78%
2020 -2.112.731 10.82%
2021 -2.469.539 14.45%
2022 -1.114.650 -121.55%
2023 -5.185 -21401.74%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Molecule Holdings Inc. Operating Cashflow
Year Operating Cashflow Growth
2015 -388.834
2016 -502.164 22.57%
2017 -501.297 -0.17%
2018 -75.495 -564.01%
2019 -677.900 88.86%
2020 -689.039 1.62%
2021 -2.407.503 71.38%
2022 -1.090.357 -120.8%
2023 -5.185 -20933.12%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Molecule Holdings Inc. Capital Expenditure
Year Capital Expenditure Growth
2015 247.732
2016 216.792 -14.27%
2017 385.188 43.72%
2018 135.868 -183.5%
2019 1.206.280 88.74%
2020 1.423.692 15.27%
2021 62.036 -2194.94%
2022 24.293 -155.37%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Molecule Holdings Inc. Equity
Year Equity Growth
2015 9.981.941
2016 10.011.294 0.29%
2017 2.925.325 -242.23%
2018 2.608.048 -12.17%
2019 3.285.426 20.62%
2020 2.577.398 -27.47%
2021 515.242 -400.23%
2022 -2.711.223 119%
2023 -4.265.278 36.44%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Molecule Holdings Inc. Assets
Year Assets Growth
2015 10.478.132
2016 10.381.537 -0.93%
2017 3.164.694 -228.04%
2018 2.862.023 -10.58%
2019 3.842.605 25.52%
2020 4.085.184 5.94%
2021 4.806.873 15.01%
2022 2.870.719 -67.44%
2023 2.390.348 -20.1%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Molecule Holdings Inc. Liabilities
Year Liabilities Growth
2015 496.191
2016 370.242 -34.02%
2017 239.369 -54.67%
2018 253.974 5.75%
2019 557.178 54.42%
2020 1.507.786 63.05%
2021 4.291.630 64.87%
2022 5.581.943 23.12%
2023 6.655.626 16.13%

Molecule Holdings Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.01
Price to Earning Ratio
-0.23x
Price To Sales Ratio
0.37x
POCF Ratio
-3.06
PFCF Ratio
-3.06
Price to Book Ratio
-0.06
EV to Sales
6.86
EV Over EBITDA
-10.83
EV to Operating CashFlow
-57.03
EV to FreeCashFlow
-57.03
Earnings Yield
-4.39
FreeCashFlow Yield
-0.33
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.1
Graham NetNet
-0.06

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.07
ROE
0.27
Return On Assets
-0.45
Return On Capital Employed
0.11
Net Income per EBT
1
EBT Per Ebit
2.33
Ebit per Revenue
-0.69
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
1.19
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.23
Operating Profit Margin
-0.69
Pretax Profit Margin
-1.62
Net Profit Margin
-1.62

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-2.98
Return on Tangible Assets
-0.45
Days Sales Outstanding
145.71
Days Payables Outstanding
1087.35
Days of Inventory on Hand
172.32
Receivables Turnover
2.5
Payables Turnover
0.34
Inventory Turnover
2.12
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,04
Tangible Book Value per Share
-0.04
Shareholders Equity per Share
-0.04
Interest Debt per Share
0.05
Debt to Equity
-1.04
Debt to Assets
1.85
Net Debt to EBITDA
-10.24
Current Ratio
0.12
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-4219805
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
371828.5
Debt to Market Cap
18.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Molecule Holdings Inc. Dividends
Year Dividends Growth

Molecule Holdings Inc. Profile

About Molecule Holdings Inc.

Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. The company is based in Lansdowne, Canada.

CEO
Mr. David Reingold
Employee
0
Address
591 Reynolds Road
Lansdowne, K0E 1L0

Molecule Holdings Inc. Executives & BODs

Molecule Holdings Inc. Executives & BODs
# Name Age
1 Mr. Andre D. Audet B.Comm
Co-Founder, Chairman of the Board & Interim Chief Financial Officer
70
2 Mr. David Reingold
Chief Executive Officer, President & Director
70
3 Dr. Amy Proulx
Co-Founder & Independent Director
70
4 Dr. Philip Waddington
Chief Operating Officer & Director
70
5 Ms. Becky Griffin
Chief Innovation Officer
70
6 Mr. Tiago Zamponi
Head of Provincial Sales
70

Molecule Holdings Inc. Competitors